Fisher CJ Jr - Search Results

1

Removal of clinically relevant SARS-CoV-2 variants by an affinity resin containing Galanthus nivalis agglutinin.

Gooldy M, Roux CM, LaRosa SP, Spaulding N, Fisher CJ Jr. Gooldy M, et al. Among authors: fisher cj jr. PLoS One. 2022 Jul 28;17(7):e0272377. doi: 10.1371/journal.pone.0272377. eCollection 2022. PLoS One. 2022. PMID: 35901224 Free PMC article.

2

Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection.

Amundson DE, Shah US, de Necochea-Campion R, Jacobs M, LaRosa SP, Fisher CJ Jr. Amundson DE, et al. Among authors: fisher cj jr. Front Med (Lausanne). 2021 Oct 8;8:744141. doi: 10.3389/fmed.2021.744141. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34692735 Free PMC article.

3

Body temperature and mortality in patients with acute respiratory distress syndrome.

Schell-Chaple HM, Puntillo KA, Matthay MA, Liu KD; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network. Schell-Chaple HM, et al. Am J Crit Care. 2015 Jan;24(1):15-23. doi: 10.4037/ajcc2015320. Am J Crit Care. 2015. PMID: 25554550 Free PMC article. Clinical Trial.

4

Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.

Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA; NHLBI ARDS Network. Calfee CS, et al. Lancet Respir Med. 2014 Aug;2(8):611-20. doi: 10.1016/S2213-2600(14)70097-9. Epub 2014 May 19. Lancet Respir Med. 2014. PMID: 24853585 Free PMC article. Clinical Trial.

5

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.

Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, Thompson BT, Matthay MA; National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network. Calfee CS, et al. Crit Care Med. 2011 Apr;39(4):711-7. doi: 10.1097/CCM.0b013e318207ec3c. Crit Care Med. 2011. PMID: 21283009 Free PMC article.

6

Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.

Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA; NHLBI ARDS Clinical Trials Network. Ware LB, et al. Chest. 2010 Feb;137(2):288-96. doi: 10.1378/chest.09-1484. Epub 2009 Oct 26. Chest. 2010. PMID: 19858233 Free PMC article. Clinical Trial.

7

Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.

Calfee CS, Eisner MD, Parsons PE, Thompson BT, Conner ER Jr, Matthay MA, Ware LB; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Calfee CS, et al. Intensive Care Med. 2009 Feb;35(2):248-57. doi: 10.1007/s00134-008-1235-0. Epub 2008 Aug 1. Intensive Care Med. 2009. PMID: 18670758 Free PMC article. Review.

8

Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.

LaRosa SP, Opal SM, Utterback B, Yan SC, Helterbrand J, Simpson AJ, Chaowagul W, White NJ, Fisher CJ Jr. LaRosa SP, et al. Among authors: fisher cj jr. Int J Infect Dis. 2006 Jan;10(1):25-31. doi: 10.1016/j.ijid.2005.06.001. Epub 2005 Nov 11. Int J Infect Dis. 2006. PMID: 16290015 Free article. Clinical Trial.

9

Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000.

Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, Fisher CJ Jr, Faist E, Reinhart K. Marshall JC, et al. Among authors: fisher cj jr. Crit Care Med. 2003 May;31(5):1560-7. doi: 10.1097/01.CCM.0000065186.67848.3A. Crit Care Med. 2003. PMID: 12771633

10

Efficacy and safety of recombinant human activated protein C for severe sepsis.

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Bernard GR, et al. Among authors: fisher cj jr. N Engl J Med. 2001 Mar 8;344(10):699-709. doi: 10.1056/NEJM200103083441001. N Engl J Med. 2001. PMID: 11236773 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page